REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

18/07/2018 10:35

RNS Number : 0285V
Morgan Stanley
18 July 2018
 


 
FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 




(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


17 JULY 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES - Shire plc




 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 




 
Class of relevant security:


 
Ordinary




 
 


Interests


Short positions




Number


%


Number


%




(1) Relevant securities owned and/or controlled:


3,026,795


0.39


8,221,652


1.05




(2) Cash-settled derivatives:
 


7,997,902


1.02


2,655,400


0.34




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


0


0.00


0


0.00




 
     TOTAL:


11,024,697


1.41


10,877,052


1.39




 
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 




Class of relevant security in relation to which subscription right exists:


N/A




Details, including nature of the rights concerned and relevant percentages:


N/A




 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 




Class of relevant security


 Purchases/sales


 Total   number of securities


 Highest price per unit paid/received


 Lowest price per unit paid/received




 Ordinary


 PURCHASES


 1,157,100


 4,745.3320 JPY


 4,671.0000 JPY




 Ordinary


 SALES


 1,443,900


 4,741.0000 JPY


 4,660.0000 JPY




 
(b)        Cash-settled derivative transactions
 




Class of relevant security


 Product description
            e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per unit




Ordinary


CFD


LONG


1200


4720.7500 JPY




Ordinary


CFD


LONG


800


4728.7500 JPY




Ordinary


CFD


SHORT


2100


4689.0000 JPY




Ordinary


CFD


SHORT


2200


4689.0000 JPY




Ordinary


CFD


SHORT


8500


4714.8527 JPY




Ordinary


CFD


LONG


4400


4730.0000 JPY




Ordinary


CFD


LONG


1182


4685.9475 JPY




Ordinary


CFD


LONG


300


4723.0000 JPY




Ordinary


CFD


SHORT


4300


4717.4418 JPY




Ordinary


CFD


SHORT


800


4728.5000 JPY




Ordinary


CFD


SHORT


10100


4720.2970 JPY




Ordinary


CFD


LONG


13100


4701.6984 JPY




Ordinary


CFD


SHORT


5200


4727.3846 JPY




Ordinary


CFD


LONG


1800


4689.0000 JPY




Ordinary


CFD


SHORT


7400


4729.7484 JPY




Ordinary


CFD


SHORT


8500


4729.7484 JPY




Ordinary


CFD


SHORT


40500


4721.8814 JPY




Ordinary


CFD


LONG


46000


4696.8913 JPY




Ordinary


CFD


LONG


2900


4723.2417 JPY




Ordinary


CFD


LONG


1800


4730.8050 JPY




Ordinary


CFD


SHORT


1800


4723.9283 JPY




Ordinary


CFD


LONG


100


4730.0000 JPY




Ordinary


CFD


LONG


215600


4704.2940 JPY




Ordinary


CFD


LONG


5800


4730.0000 JPY




Ordinary


CFD


LONG


2200


4730.0000 JPY




Ordinary


CFD


LONG


6900


4730.0000 JPY




Ordinary


CFD


LONG


4400


4730.0000 JPY




Ordinary


CFD


LONG


3300


4722.1418 JPY




Ordinary


CFD


SHORT


1400


4730.0000 JPY




Ordinary


CFD


LONG


200


4689.0000 JPY




Ordinary


CFD


SHORT


800


4728.7500 JPY




Ordinary


CFD


SHORT


200


4724.5000 JPY




Ordinary


CFD


LONG


1800


4689.0000 JPY




Ordinary


CFD


LONG


2800


4728.9592 JPY




Ordinary


CFD


SHORT


400


4726.0000 JPY




Ordinary


CFD


LONG


80600


4715.9051 JPY




 
 
 (c)       Stock-settled derivative transactions (including options)               
 
(i)         Writing, selling, purchasing or varying
 




Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit




N/A


N/A


N/A


N/A


N/A


N/A


N/A


N/A




 
(ii)        Exercise
 




Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




N/A


N/A


N/A


N/A


N/A




 
(d)        Other dealings (including subscribing for new securities)
 




Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)




N/A


N/A


N/A


N/A




 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 




Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
None
 




 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 




Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
None
 




 
(c)        Attachments
 




Is a Supplemental Form 8 (Open Positions) attached?


NO




 
 




Date of disclosure:


18 JULY 2018




Contact name:


Craig Horsley




Telephone number:


+44(141) 245 7736




 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEANXPFAPPEEF